Pharma Focus Asia

Berkshire Sterile Plans to Expand Lyophilisation Capacity in USA


Berkshire Sterile Manufacturing plans to add an additional lyophiliser to their infrastructure in USA.


The lyophilisation capacity doubles from 35,000 10R vials to 70,000 10R vials, and aims to address the critical need for its clients and ensure seamless accommodation of their requirements.

The new lyophiliser will be leveraging the resources from the infrastructure that was added in 2021, which indicates a strategic approach to optimising their existing capabilities.

Furthermore, by incorporating the same automated loading and unloading systems as their current lyophiliser, aims to build on lessons learnt from their existing operations, thereby streamlining their processes and ensuring efficiency.

It is anticipated that the lyophilisation of GMP (Good Manufacturing Practise) will be adding newly lyophiliser by the fourth quarter of 2025.


Name  Berkshire Sterile Manufacturing
Type    New Construction
Year     2025

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024